Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Julphar
Citi
McKinsey
Teva
Merck
Deloitte
Dow
Cantor Fitzgerald
Queensland Health

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017351

« Back to Dashboard

NDA 017351 describes CORTIFOAM, which is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from two suppliers. Additional details are available on the CORTIFOAM profile page.

The generic ingredient in CORTIFOAM is hydrocortisone acetate. There are sixty-four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate profile page.
Summary for 017351
Tradename:CORTIFOAM
Applicant:Mylan Speciality Lp
Ingredient:hydrocortisone acetate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Pharmacology for NDA: 017351
Suppliers and Packaging for NDA: 017351
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CORTIFOAM hydrocortisone acetate AEROSOL, METERED;RECTAL 017351 NDA Meda Pharmaceuticals 0037-6830 0037-6830-15 1 CANISTER in 1 CARTON (0037-6830-15) > 15 g in 1 CANISTER
CORTIFOAM hydrocortisone acetate AEROSOL, METERED;RECTAL 017351 NDA Alaven Pharmaceutical LLC 68220-140 68220-140-15 1 CONTAINER in 1 CARTON (68220-140-15) > 15 g in 1 CONTAINER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, METERED;RECTALStrength10%
Approval Date:Feb 10, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Argus Health
US Department of Justice
Harvard Business School
Chinese Patent Office
QuintilesIMS
Cerilliant
Julphar
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot